HIGHLIGHTS
- who: Sanghyun Kim and collaborators from the Department of Internal Medicine, College of Medicine, University, have published the research work: Sirtuin 7 Inhibitor Attenuates Colonic Mucosal Immune Activation in Miceu2014Potential Therapeutic Target in Inflammatory Bowel Disease, in the Journal: Biomedicines 2022, 2693 of /2022/
- what: The authors also observed that the degree of clinical inflammation was improved in SIRT7-treated the study demonstrated that SIRT7 inhibition attenuated the inflammatory response in the colon of suggesting a possible role for SIRT7 in the pathogenesis of immune-mediated intestinal inflammation. The authors successfully evaluated a novel pathway . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.